Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Gross Profit: 2011-2024

Historic Gross Profit for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $219.6 million.

  • Adma Biologics' Gross Profit rose 26.76% to $75.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $267.3 million, marking a year-over-year increase of 42.70%. This contributed to the annual value of $219.6 million for FY2024, which is 146.85% up from last year.
  • Latest data reveals that Adma Biologics reported Gross Profit of $219.6 million as of FY2024, which was up 146.85% from $88.9 million recorded in FY2023.
  • Over the past 5 years, Adma Biologics' Gross Profit peaked at $219.6 million during FY2024, and registered a low of -$19.1 million during FY2020.
  • For the 3-year period, Adma Biologics' Gross Profit averaged around $114.6 million, with its median value being $88.9 million (2023).
  • Data for Adma Biologics' Gross Profit shows a peak YoY surged of 2,906.39% (in 2022) over the last 5 years.
  • Adma Biologics' Gross Profit (Yearly) stood at -$19.1 million in 2020, then skyrocketed by 106.15% to $1.2 million in 2021, then spiked by 2,906.39% to $35.3 million in 2022, then soared by 152.21% to $88.9 million in 2023, then soared by 146.85% to $219.6 million in 2024.